Johnson & Johnson

Johnson & Johnson Shares Early OMNY-AF Pilot Study Results at the 2026 AF Symposium

Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium Johnson & Johnson today announced 12-month pilot-phase data from the OMNY-AF study, evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation…

Read MoreJohnson & Johnson Shares Early OMNY-AF Pilot Study Results at the 2026 AF Symposium
Celebrating

Celebrating 24 Years of Give Kids A Smile: A Lasting Legacy of Brighter Smiles

A Legacy of Brighter Smiles: Celebrating 24 Years of the Give Kids A Smile Program The American Dental Association Foundation (ADAF) is officially kicking off Give Kids A Smile® (GKAS) 2026 at UTHealth Houston School of Dentistry, marking 24 years of transforming children’s lives…

Read MoreCelebrating 24 Years of Give Kids A Smile: A Lasting Legacy of Brighter Smiles
Mainstay Medical

Mainstay Medical Secures Exclusive Blue Cross Blue Shield of North Dakota Coverage for ReActiv8®

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for…

Read MoreMainstay Medical Secures Exclusive Blue Cross Blue Shield of North Dakota Coverage for ReActiv8®
Asundexian

Asundexian Cuts Stroke Risk by 26% With No Rise in Major Bleeding, Bayer Reports

Bayer’s Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus Placebo Bayer today presented the results from the global, pivotal Phase III OCEANIC-STROKE…

Read MoreAsundexian Cuts Stroke Risk by 26% With No Rise in Major Bleeding, Bayer Reports
Supplemental

Supplemental Screening Program Celebrates 20 Years, Urges Eligible Individuals to Join

National Supplemental Screening Program Celebrates 20 Years of Service; Eligible Individuals Encouraged to Participate The U.S. Department of Energy (DOE) National Supplemental Screening Program (NSSP), managed by ORAU, is celebrating 20 years of continued service and encourages those eligible to participate in…

Read MoreSupplemental Screening Program Celebrates 20 Years, Urges Eligible Individuals to Join
Morgan Stanley

Morgan Stanley and the American Heart Association Unite for the 17th Go Red Women’s Leadership Event

Morgan Stanley to Host 17th Annual Go Red Women’s Leadership Event in Collaboration with the American Heart Association In special recognition of the Go Red for Women® campaign, Morgan Stanley Wealth Management will collaborate with the American Heart Association in Westchester and Fairfield…

Read MoreMorgan Stanley and the American Heart Association Unite for the 17th Go Red Women’s Leadership Event
Humana

Humana Named KCTCS Education First Employer, Introduces Nursing Scholars Program

Humana Named KCTCS Education First Employer, Announces Humana Scholars Program for Nursing Students Humana is investing in a new program with Jefferson Community and Technical College to strengthen and support Kentucky’s nursing workforce. In announcing the launch of the Humana Scholars…

Read MoreHumana Named KCTCS Education First Employer, Introduces Nursing Scholars Program
AOP Health

AOP Health’s Rapiblyk® (landiolol) Becomes Available Through Vizient® Contract

AOP Health’s Rapiblyk® (landiolol) Now Accessible via Vizient® Contract AOP Health US, LLC announced today that Rapiblyk® (landiolol) is now more widely available across the United States through contract with Vizient®, the nation’s largest provider-driven healthcare performance improvement company. Hospitals and…

Read MoreAOP Health’s Rapiblyk® (landiolol) Becomes Available Through Vizient® Contract